STAT Plus: Wait … what? Mannkind posts best-ever quarter of inhaled insulin product sales
SANOFI
Mannkind delivered strong financial results for the fourth quarter — noteworthy for the best-ever quarterly sales of the inhaled insulin, Afrezza.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario